Phase 1 Clinical Study of JTS-661 - Pharmacokinetic Study in Patients on Hemodialysis -

Status

Unknown

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080223686

Enrollment

Registered

2017-10-20

Start date

2017-10-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Japanese patients with CKD on maintenance hemodialysis

Interventions

investigational material(s) Generic name etc : JTS-661 INN of investigational material : Serlopitant Therapeutic category code : 449 Other antiallergic agents Dosage and Administration for Investigati

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Japanese patients aged 20 to 80 years (inclusive) at consent; however, female subjects must be postmenopausal - Patients on hemodialysis (including hemodiafiltration) three times a week for at least 12 weeks before the screening visit - Outpatients

Exclusion criteria

Exclusion criteria:

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026